- Home
- ACOG vs ORMP Comparison
ACOG vs ORMP Comparison
Compare ACOG & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACOG
- ORMP
- Stock Information
- Founded
- ACOG 2000
- ORMP 2002
- Country
- ACOG Canada
- ORMP United States
- Employees
- ACOG N/A
- ORMP N/A
- Industry
- ACOG
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- ACOG
- ORMP Health Care
- Exchange
- ACOG Nasdaq
- ORMP Nasdaq
- Market Cap
- ACOG 80.3M
- ORMP 90.2M
- IPO Year
- ACOG N/A
- ORMP N/A
- Fundamental
- Price
- ACOG $9.74
- ORMP $2.27
- Analyst Decision
- ACOG Strong Buy
- ORMP Hold
- Analyst Count
- ACOG 1
- ORMP 1
- Target Price
- ACOG $20.00
- ORMP N/A
- AVG Volume (30 Days)
- ACOG 73.8K
- ORMP 99.1K
- Earning Date
- ACOG 11-14-2025
- ORMP 11-06-2025
- Dividend Yield
- ACOG N/A
- ORMP N/A
- EPS Growth
- ACOG N/A
- ORMP N/A
- EPS
- ACOG N/A
- ORMP N/A
- Revenue
- ACOG $4,586,341.00
- ORMP $2,000,000.00
- Revenue This Year
- ACOG N/A
- ORMP N/A
- Revenue Next Year
- ACOG $149.89
- ORMP N/A
- P/E Ratio
- ACOG N/A
- ORMP N/A
- Revenue Growth
- ACOG N/A
- ORMP N/A
- 52 Week Low
- ACOG $3.75
- ORMP $1.82
- 52 Week High
- ACOG $11.54
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- ACOG 60.84
- ORMP 57.49
- Support Level
- ACOG $8.01
- ORMP $2.17
- Resistance Level
- ACOG $9.86
- ORMP $2.45
- Average True Range (ATR)
- ACOG 0.43
- ORMP 0.07
- MACD
- ACOG 0.22
- ORMP 0.02
- Stochastic Oscillator
- ACOG 89.08
- ORMP 55.88
About ACOG Alpha Cognition Inc. Common Stock
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.